The role of human papillomavirus-16 and matrix metalloproteinase-9 in pathogenesis of uterine cervical neoplasia (original) (raw)

The role of human papillomavirus-16 and matrix metalloproteinase-9 in pathogenesis of uterine cervical neoplasia Uterus servikal neoplazi patogenezinde insan papillomavirüs-16 ve matriks metalloproteinaz-9'un rolü

Haider Sabah Kadhim

2012

View PDFchevron_right

HPV16 Oncoproteins Promote Cervical Cancer Invasiveness by Upregulating Specific Matrix Metalloproteinases

Jittranan Kaewprag

PLoS ONE, 2013

View PDFchevron_right

MMP-2 AND MMP-9 PROTEIN DETERMINATION IN CERVICAL CANCER SAMPLES

Editor Biolife Journal

Biolife, 2014

View PDFchevron_right

MMP-9 expression increases according to the grade of squamous intraepithelial lesion in cervical smears

Michelle Discacciati

Diagnostic Cytopathology, 2014

View PDFchevron_right

Matrix metalloproteinases-2 and -9 in cervical cancer: different roles in tumor progression

György Horvath, R. Willen

International Journal of Gynecological Cancer, 2006

View PDFchevron_right

HPV16 Oncoproteins Induce MMPs/RECK-TIMP-2 Imbalance in Primary Keratinocytes: Possible Implications in Cervical Carcinogenesis

Lara Termini

PLoS ONE, 2012

View PDFchevron_right

Expression of matrix metalloproteinase (MMP)-2, MMP-9, MMP-13, and MT1-MMP in skin tumors of human papillomavirus type 8 transgenic mice

Gian Paolo Marcuzzi

Experimental Dermatology, 2006

View PDFchevron_right

MMP-9/RECK imbalance: a mechanism associated with high-grade cervical lesions and genital infection by Human Papillomavirus (HPV) and Chlamydia trachomatis Running title: MMP-9/RECK imbalance in cervical carcinogenesis Key words: Matrix Metalloproteinases; RECK protein; Cervical Intraepithelial Neop

Michelle Discacciati

2015

View PDFchevron_right

MMP-9/RECK imbalance: a mechanism associated with high-grade cervical lesions and genital infection by Human Papillomavirus (HPV) and Chlamydia trachomatis

Michelle Discacciati

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2015

View PDFchevron_right

Comparative evaluation of nm23 and p16 expression as biomarkers of high-risk human papillomavirus infection and cervical intraepithelial neoplasia 2+ lesions of the uterine cervix

Maria Benevolo, Ferdinando Marandino

Histopathology, 2010

View PDFchevron_right

Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer

Ho-hsiung Lin

Cancer research, 2003

View PDFchevron_right

Cellular and Viral Markers in Human Papillomavirus Related Cervical Lesions Progression

Anca Botezatu

View PDFchevron_right

High risk HPV in situ hybridization, p16 INK 4A, and survivin expressions in cervical carcinomas and intraepithelial neoplasms: evaluation of prognostic factors

Nusret Erdogan

European journal of gynaecological oncology

View PDFchevron_right

Co-expression of metalloproteinases 11 and 12 in cervical scrapes cells from cervical precursor lesions.

Raúl Peralta

View PDFchevron_right

Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix

laura pirami

Journal of Clinical Pathology, 1997

View PDFchevron_right

The Role of the Human Papillomavirus (HPV) in Cervical Cancer: A Review about HPV-Induced Carcinogenesis and Its Epidemiology, Diagnosis, Management and Prevention

Renald Blundell

International Journal of Medical Students

View PDFchevron_right

Expression profile of microRNA-29b and its action on matrix metalloproteinase 2 (MMP-2) in the cervical carcinogenic process

Giwellington Albuquerque

Research, Society and Development, 2021

View PDFchevron_right

Increase in Viral Load, Viral Integration, and Gain of Telomerase Genes during Uterine Cervical Carcinogenesis can be Simultaneously Assessed by the HPV 16/18 MLPA-Assay

Anton Hopman

The American Journal of Pathology, 2010

View PDFchevron_right

Matrix metalloproteinase 1 gene polymorphism as a prognostic predictor of invasive cervical cancer

Mu Yu

Gynecologic Oncology, 2005

View PDFchevron_right

Current scenario of biomarkers in cervical cancer and oncogenesis by HPV

Danielle Traesel

Jornal Brasileiro de Doenças Sexualmente Transmissíveis, 2019

View PDFchevron_right

Medical Students Review The Role of the Human Papillomavirus (HPV) in Cervical Cancer: A Review about HPV-Induced Carcinogenesis and Its Epidemiology, Diagnosis, Management and Prevention

Renald Blundell

View PDFchevron_right

Matrix Metallo Proteinases in carcinoma of Cervix - A Review

Ramakrishna Devaki

View PDFchevron_right

Exploratory cross-sectional study to evaluate the metalloproteinases role as ‘immunoscore’ for HPV-induced cervical lesions

Eric Roma

View PDFchevron_right

Identification and validation of genes involved in cervical tumourigenesis

Thangarajan Rajkumar

BMC Cancer, 2011

View PDFchevron_right

Absence ofp15andp16Gene Alterations in Primary Cervical Carcinoma Tissues and Cell Lines with Human Papillomavirus Infection

dae young kim

Gynecologic Oncology, 1998

View PDFchevron_right

High level HPV-16 E7 oncoprotein expression correlates with reduced pRb-levels in cervical biopsies

Andreas Laich

The FASEB Journal, 2004

View PDFchevron_right

Increased Expression and Activation of Gelatinolytic Matrix Metalloproteinases Is Associated with the Progression and Recurrence of Human Cervical Cancer1

Su-ming Hsu

2003

View PDFchevron_right

Identification of High-Risk Human Papillomavirus (hrHPV)-Associated Genes in Early Stage Cervical Squamous Cell Carcinomas

Imam Malik

Journal of International Medical Research, 2011

View PDFchevron_right